The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ACCURAY INCCOM0043971054,6001,000,000SH SOLE 1,000,00000
ALLERGAN PLCSHSG0177J10821,001100,000SH SOLE 100,00000
BIOSCRIP INCCOM09069N1088,8408,500,000SH SOLE 8,500,00000
GILEAD SCIENCES INCCOM37555810335,805500,000SH SOLE 500,00000
HEALTHWAYS INCCOM422245100102,3754,500,000SH SOLE 4,500,00000
IMPAX LABORATORIES INCCOM45256B10126,5002,000,000SH SOLE 2,000,00000
KINDRED HEALTHCARE INCCOM49458010333,3634,250,000SH SOLE 4,250,00000
LIFEPOINT HEALTH INCCOM53219L10922,720400,000SH SOLE 400,00000
MYLAN N VSHS EURON5946510928,613750,000SH SOLE 750,00000
MYRIAD GENETICS INCCOM62855J10419,1711,150,000SH SOLE 1,150,00000
QUORUM HEALTH CORPCOM74909E10618,1752,500,000SH SOLE 2,500,00000
SELECT MED HLDGS CORPCOM81619Q105132,50010,000,000SH SOLE 10,000,00000
SUPERVALU INCCOM86853610386,25518,469,921SH SOLE 18,469,92100
SYNERON MEDICAL LTDORD SHSM8724510229,4003,500,000SH SOLE 3,500,00000
VIVUS INCCOM92855110015,62613,587,460SH SOLE 13,587,46000